SCHEMBL945622

SCHEMBL945622

CC(=O)Nc1ccc(-c2nc(SCc3cccc(CN4CCN(Cc5ccccc5)CC4)n3)nc(N)c2C#N)cc1

nearest known ligand 0.65

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 11/20 0.65
ADORA2A P29274 3/20 0.65
PDE4B Q07343 5/20 0.43
ADORA3 P0DMS8 2/20 0.42
ADORA2B P29275 1/20 0.42
ACMSD Q8TDX5 1/20 0.41
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
HPGD P15428 1/20 0.40
CYP2C19 P33261 1/20 0.40
PPARG P37231 1/20 0.40
HTT P42858 1/20 0.40
KMT2A Q03164 1/20 0.40
NCOA2 Q15596 1/20 0.40
NCOA1 Q15788 1/20 0.40
ATM Q13315 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12359336 0.92 ADORA1 (0.68) ADORA1ADORA2APDE4BADORA3ADORA2B
SCHEMBL947289 0.91 ADORA1 (0.66) ADORA1ADORA2APDE4BADORA3ADORA2B
SCHEMBL946673 0.90 ADORA1 (0.64) ADORA1ADORA2AADORA3ADORA2B
Hydrochloric Acid SCHEMBL946831 0.89 ADORA1 (0.63) ADORA1ADORA2APDE4BADORA3ADORA2B
Hydrochloric Acid SCHEMBL947172 0.87 ADORA1 (0.70) ADORA1ADORA2APDE4BADORA3ADORA2B
SCHEMBL945707 0.87 ADORA1 (0.70) ADORA1ADORA2APDE4BADORA3ADORA2B
SCHEMBL946650 0.87 ADORA1 (0.64) ADORA1ADORA2APDE4BADORA3ADORA2B
Hydrochloric Acid SCHEMBL946482 0.86 ADORA1 (0.69) ADORA1ADORA2APDE4BADORA3ADORA2B
Hydrochloric Acid SCHEMBL945489 0.86 ADORA1 (0.67) ADORA1ADORA2AADORA3ADORA2BALDH1A1
Hydrochloric Acid SCHEMBL947480 0.85 ADORA1 (0.73) ADORA1ADORA2AADORA3ADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7989446-B2 4-amino 5-cyanopyrimidine derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2011-08-02 US disclosed
US-20110009620-A1 4-Amino-5-cyanopyrimidine derivatives OTSUKA PHARMACEUTICAL CO., LTD. 2011-01-13 US disclosed
US-7834002-B2 4-amino-5-cyanopyrimidine derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-11-16 US disclosed
US-20080182854-A1 4-Amino-5-Cyanopyrimidine Derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2008-07-31 US disclosed
EP-1740574-B1 4-AMINO-5-CYANOPYRIMIDINE DERIVATIVES OTSUKA PHARMA CO LTD (JP) 2007-06-27 EP disclosed
EP-1740574-A2 4-AMINO-5-CYANOPYRIMIDINE DERIVATIVES Otsuka Pharmaceutical Company, Limited (JP) 2007-01-10 EP disclosed
WO-2005105778-A2 4-AMINO-5-CYANOPYRIMIDINE DERIVATIVES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-11-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110009620-A1 4-Amino-5-cyanopyrimidine derivatives ADORA2A, ADORA1, ADORA3 ADORA1 2/4885ADORA2A 1/4885PDE4B 40/4885
US-20080182854-A1 4-Amino-5-Cyanopyrimidine Derivatives ADORA2A, ADORA1, ADORA3 ADORA1 2/4885ADORA2A 1/4885PDE4B 40/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.